SK
Shailendra Kumar Dwivedi
About Shailendra Kumar Dwivedi
Data last updated:
Shailendra Kumar Dwivedi is a Director at Segmed Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Segmed Pharmaceuticals Private Limited reported revenue of ₹5.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jan 2020 | 2020 | ₹5.4 Lakh (FY 2024) | Active |
Board colleagues of Shailendra Kumar Dwivedi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neeraj Srivastava | 08680161 | Segmed Pharmaceuticals Private Limited | Director |
| Pawan Kumar Singh | 08680162 | Segmed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shailendra Kumar Dwivedi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shailendra Kumar Dwivedi
Shailendra Kumar Dwivedi currently holds 1 directorship: Segmed Pharmaceuticals Private Limited (Director, since 27 Jan 2020, revenue ₹5.4 Lakh (FY 2024)).
Shailendra Kumar Dwivedi was first appointed on 27 Jan 2020 as Director at Segmed Pharmaceuticals Private Limited.
The current boards of Shailendra Kumar Dwivedi's companies include Neeraj Srivastava (Segmed Pharmaceuticals Private Limited), Pawan Kumar Singh (Segmed Pharmaceuticals Private Limited).